Thank you, Neil. Our consolidated financial results for the second quarter were as follows. We reported net sales of $422.9 million, up 86% compared to $227.6 million in the second quarter of 2015. Cost of goods sold was $405.2 million compared to $221.4 million in the same quarter last year. Gross profit was $17.7 million compared to $6.3 million in the second quarter of 2015. SG&A expenses were $6.1 million compared to $4 million in the second quarter of 2015. Although this represents a significant year-over-year increase, it reflects the additional operational costs associated with the merged companies. Further, our SG&A spend this quarter is lower sequentially by over $2 million, reflecting our efforts to reduce professional fees. While we remain resolute in these efforts, for conservative purposes we anticipate for the remainder of 2016 that our SG&A expenses will average $7 million to $7.5 million per quarter, consistent with our prior guidance. Income from operations was $11.6 million compared to $2.3 million in the prior-year period. Interest expense was $6.5 million compared to $1 million in the second quarter of 2015. The increase in interest expense reflects the debt we assumed in our Aventine acquisition and our decision in the second quarter to capitalize interest in our debt rather than pay cash, an option available to us under our term loan structure. This decision was not taken lightly, given that it represents a higher cost of borrowing, but given the poor margin environment in the first quarter we believe it was important to conserve cash. Benefit for income taxes was $245,000 compared to $530,000 provision in the second quarter of last year. Net income available to common stockholders was $4.7 million, or $0.11 per share, which compares to net income of $677,000, or $0.03 per share, in the year-ago period. Adjusted EBITDA was $20.4 million compared to $5.4 million last year. Now turning to our balance sheet, cash and cash equivalents were $31.7 million at June 30, 2016, compared to $52.7 million at December 31, 2015. The decrease in cash was primarily due to over $17 million in debt reductions paid out in the first quarter. On a sequential basis, cash increased $12.5 million due to stronger cash flow from operations. Working capital was $138 million at June 30, 2016, compared to $125 million at December 31, 2015. Our second-quarter capital expenditures were approximately $2.5 million, mostly related to plant improvement initiatives. We continue to focus on investments to generate meaningful near-term results through improving plant performance and carbon emission reductions. Consistent with our prior guidance we expect our full-year 2016 CapEx spend to approximate $15 million. We also continue to explore lease financing options that would fund CapEx for the remainder of the year and preserve adequate cash balances. In our efforts to lower our cost of borrowing and strengthen our balance sheet, we are actively evaluating various options to refinance our term debt. It is important to recognize that this plant debt does not mature until September 2017. We are beginning to see a long overdue thawing in the capital markets and the integration and benefits of the acquisition are now bearing fruit. Accordingly, we believe that it is in the best interests of the Company and our shareholders to take advantage of these trends and use the time available to optimize our refinancing options, and to do so on the most advantageous terms to the Company. Nonetheless, we are cognizant of the shareholder sensitivity regarding this obligation and refinancing this term debt remains one of our top priorities. With that, I'll turn the call back to Neil.